Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Central Nervous System (CNS) Lymphoma”

328 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 328 results

Not applicableUnknownNCT05347511
What this trial is testing

Study of the Pronostic Impact of Immunohistochemical, Histological and Radiological Factors in Patients With Primary Central Nervous System Lymphoma.

Who this might be right for
Rare Disease With Poor Outcome
Central Hospital, Nancy, France 94
Not applicableUnknownNCT05083936
What this trial is testing

Prospective Comparison of 18F-FDG and 18F-FET PET for Response Evaluation in Patients With Primary Central Nervous System Lymphoma

Who this might be right for
Patients With Suspected or Diagnosed Central Nervous System Lymphoma
Asan Medical Center 30
Early research (Phase 1)Ended earlyNCT03558750
What this trial is testing

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Who this might be right for
Recurrent Central Nervous System LymphomaRecurrent Diffuse Large B-Cell LymphomaRefractory Central Nervous System Lymphoma+1 more
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT07015242
What this trial is testing

The Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 65
Not applicableLooking for participantsNCT05108298
What this trial is testing

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Who this might be right for
Breast Cancer, NOSCNS Primary Tumor, NOSCervical Cancer, NOS+9 more
Eastern Cooperative Oncology Group 400
Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT06946407
What this trial is testing

Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)CNS Lymphoma Treatment
FengYan Jin 41
Not applicableLooking for participantsNCT07191431
What this trial is testing

A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）

Who this might be right for
Lymphoma Cns
Ruijin Hospital 25
Testing effectiveness (Phase 2)Study completedNCT03536039
What this trial is testing

RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Andres J. M. Ferreri 28
Not applicableStudy completedNCT00082836
What this trial is testing

Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT00210314
What this trial is testing

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma, B Cell
International Extranodal Lymphoma Study Group (IELSG) 79
Early research (Phase 1)Looking for participantsNCT07137494
What this trial is testing

MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

Who this might be right for
Primary Central Nervous System (CNS) LymphomaSecondary Central Nervous System Lymphoma
Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)Study completedNCT00293345
What this trial is testing

3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+56 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Looking for participantsNCT04807881
What this trial is testing

Phase Ib Clinical Study of Keynatinib

Who this might be right for
Lymphoma, B-Cell
Medolution Ltd. 75
Early research (Phase 1)Ended earlyNCT00253721
What this trial is testing

Melphalan With BBBD in Treating Patients With Brain Malignancies

Who this might be right for
Brain and Central Nervous System TumorsLymphomaMetastatic Cancer
OHSU Knight Cancer Institute 21
Testing effectiveness (Phase 2)UnknownNCT00455286
What this trial is testing

A Phase II Study in Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
National Health Research Institutes, Taiwan 25
Testing effectiveness (Phase 2)Looking for participantsNCT04421560
What this trial is testing

Pembrolizumab, Ibrutinib and Rituximab in PCNSL

Who this might be right for
Primary Central Nervous System LymphomaRecurrent CancerRefractory Cancer+1 more
Dana-Farber Cancer Institute 37
Testing effectiveness (Phase 2)Study completedNCT01011920
What this trial is testing

Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

Who this might be right for
Central Nervous System Lymphoma
International Extranodal Lymphoma Study Group (IELSG) 126
Testing effectiveness (Phase 2)UnknownNCT04066920
What this trial is testing

IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL

Who this might be right for
Primary Central Nervous System Lymphoma
Deok-Hwan Yang 30
Load More Results